Cargando…

Nanoparticles in Targeted Alpha Therapy

Recent advances in the field of nanotechnology application in nuclear medicine offer the promise of better therapeutic options. In recent years, increasing efforts have been made on developing nanoconstructs that can be used as carriers for immobilising alpha (α)-emitters in targeted drug delivery....

Descripción completa

Detalles Bibliográficos
Autores principales:	Majkowska-Pilip, Agnieszka, Gawęda, Weronika, Żelechowska-Matysiak, Kinga, Wawrowicz, Kamil, Bilewicz, Aleksander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408031/ https://www.ncbi.nlm.nih.gov/pubmed/32668687 http://dx.doi.org/10.3390/nano10071366

Ejemplares similares

Platinum nanoparticles labelled with iodine-125 for combined “chemo-Auger electron” therapy of hepatocellular carcinoma
por: Wawrowicz, Kamil, et al.
Publicado: (2023)

Doxorubicin- and Trastuzumab-Modified Gold Nanoparticles as Potential Multimodal Agents for Targeted Therapy of HER2+ Cancers
por: Żelechowska-Matysiak, Kinga, et al.
Publicado: (2023)

Oxidative Status as an Attribute for Selective Antitumor Activity of Platinum-Containing Nanoparticles against Hepatocellular Carcinoma
por: Wawrowicz, Kamil, et al.
Publicado: (2022)

Au@(109)Pd core–shell nanoparticle conjugated to trastuzumab for the therapy of HER2+ cancers: studies on the applicability of (109)Pd/(109m)Ag in vivo generator in combined β(−) auger electron therapy
por: Gharibkandi, Nasrin Abbasi, et al.
Publicado: (2023)

Multimodal Radiobioconjugates of Magnetic Nanoparticles Labeled with (44)Sc and (47)Sc for Theranostic Application
por: Ünak, Perihan, et al.
Publicado: (2023)

Improvement of the Effectiveness of HER2+ Cancer Therapy by Use of Doxorubicin and Trastuzumab Modified Radioactive Gold Nanoparticles
por: Żelechowska-Matysiak, Kinga, et al.
Publicado: (2023)

Au@Pt Core-Shell Nanoparticle Bioconjugates for the Therapy of HER2+ Breast Cancer and Hepatocellular Carcinoma. Model Studies on the Applicability of (193m)Pt and (195m)Pt Radionuclides in Auger Electron Therapy
por: Wawrowicz, Kamil, et al.
Publicado: (2021)

Lipidic Cubic-Phase Nanoparticles (Cubosomes) Loaded with Doxorubicin and Labeled with (177)Lu as a Potential Tool for Combined Chemo and Internal Radiotherapy for Cancers
por: Cytryniak, Adrianna, et al.
Publicado: (2020)

Hybrid Radiobioconjugated Superparamagnetic Iron Oxide-Based Nanoparticles for Multimodal Cancer Therapy
por: Żuk, Michał, et al.
Publicado: (2021)

(198)Au-Coated Superparamagnetic Iron Oxide Nanoparticles for Dual Magnetic Hyperthermia and Radionuclide Therapy of Hepatocellular Carcinoma
por: Gharibkandi, Nasrin Abbasi, et al.
Publicado: (2023)

Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy
por: Gawęda, Weronika, et al.
Publicado: (2020)

Functionalized TiO(2) nanoparticles labelled with (225)Ac for targeted alpha radionuclide therapy
por: Cędrowska, Edyta, et al.
Publicado: (2018)

Cubosomal Lipid Formulation for Combination Cancer Treatment: Delivery of a Chemotherapeutic Agent and Complexed α-Particle Emitter (213)Bi
por: Cytryniak, Adrianna, et al.
Publicado: (2022)

Hybrid System for Local Drug Delivery and Magnetic Hyperthermia Based on SPIONs Loaded with Doxorubicin and Epirubicin
por: Nieciecka, Dorota, et al.
Publicado: (2021)

1,2-Benzenedithiol and Toluene-3,4-dithiol Arsenic(III) Complexes—Synthesis, Structure, Spectroscopic Characterization and Toxicological Studies
por: Lyczko, Monika, et al.
Publicado: (2019)

Nanostructures as Radionuclide Carriers in Auger Electron Therapy
por: Gharibkandi, Nasrin Abbasi, et al.
Publicado: (2022)

Multifunctional Nanoparticles Based on Iron Oxide and Gold-198 Designed for Magnetic Hyperthermia and Radionuclide Therapy as a Potential Tool for Combined HER2-Positive Cancer Treatment
por: Żuk, Michał, et al.
Publicado: (2022)

Design and Evaluation of (223)Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy–Part I
por: Czerwińska, Malwina, et al.
Publicado: (2020)

Trastuzumab-Modified Gold Nanoparticles Labeled with (211)At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer
por: Dziawer, Łucja, et al.
Publicado: (2019)

Effect of Surface Functionalization on the Cellular Uptake and Toxicity of Nanozeolite A
por: Męczyńska-Wielgosz, Sylwia, et al.
Publicado: (2016)

The Significance of NK1 Receptor Ligands and Their Application in Targeted Radionuclide Tumour Therapy
por: Majkowska-Pilip, Agnieszka, et al.
Publicado: (2019)

Lanthanide-Doped SPIONs Bioconjugation with Trastuzumab for Potential Multimodal Anticancer Activity and Magnetic Hyperthermia
por: Gawęda, Weronika, et al.
Publicado: (2020)

Functionalized NaA nanozeolites labeled with (224,225)Ra for targeted alpha therapy
por: Piotrowska, Agata, et al.
Publicado: (2013)

Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with (225)Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer
por: Cędrowska, Edyta, et al.
Publicado: (2020)

Application of Neurokinin-1 Receptor in Targeted Strategies for Glioma Treatment. Part I: Synthesis and Evaluation of Substance P Fragments Labeled with (99m)Tc and (177)Lu as Potential Receptor Radiopharmaceuticals
por: Majkowska-Pilip, Agnieszka, et al.
Publicado: (2018)

Targeted Radionuclide Therapy of Prostate Cancer—From Basic Research to Clinical Perspectives
por: Czerwińska, Malwina, et al.
Publicado: (2020)

Synthesis, characterization, and interactions of single-walled carbon nanotubes modified with doxorubicin with Langmuir–Blodgett biomimetic membranes
por: Matyszewska, Dorota, et al.
Publicado: (2018)

Obstacles and Recommendations for Clinical Translation of Nanoparticle System-Based Targeted Alpha-Particle Therapy
por: Kleynhans, Janke, et al.
Publicado: (2021)

Cyclotron production of (43)Sc for PET imaging
por: Walczak, Rafał, et al.
Publicado: (2015)

Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle
por: Dekempeneer, Yana, et al.
Publicado: (2016)

Not Just Another Scaffolding Protein Family: The Multifaceted MPPs
por: Chytła, Agnieszka, et al.
Publicado: (2020)

Advances in targeted alpha therapy for prostate cancer
por: De Vincentis, G, et al.
Publicado: (2019)

Targeted alpha anticancer therapies: update and future prospects
por: Allen, Barry J, et al.
Publicado: (2014)

Development of Targeted Alpha Particle Therapy for Solid Tumors
por: Tafreshi, Narges K., et al.
Publicado: (2019)

Separation of Radionuclides from Spent Decontamination Fluids via Adsorption onto Titanium Dioxide Nanotubes after Photocatalytic Degradation
por: Lyczko, Monika, et al.
Publicado: (2020)

Incretins in the Therapy of Diabetic Kidney Disease
por: Przezak, Agnieszka, et al.
Publicado: (2021)

Targeted Alpha Therapy: Progress in Radionuclide Production, Radiochemistry, and Applications
por: Nelson, Bryce J. B., et al.
Publicado: (2020)

Targeted Alpha-Particle Therapy: A Review of Current Trials
por: Jang, Albert, et al.
Publicado: (2023)

Targeted Alpha Therapy (TAT) with Single-Domain Antibodies (Nanobodies)
por: Hurley, Kate, et al.
Publicado: (2023)

Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia—Therapy and Toxicity Mechanisms
por: Lejman, Monika, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lvqn6smlio3uabrcj6cob58f4k